Mr. Torin JX Halvorson, Canada
Optimization of an activation-induced marker assay to measure vaccine-induced immunity to SARS-CoV-2 in transplant recipients

Dr. Marcella Franquesa, Spain
Regulatory B cells biomarker discovery and their prognostic value of improved graft outcome and rejection risk in kidney transplant patients

Mrs. Séverine Bézie, France
Transfer of CD8+T regulatory cells GMP manufacturing for clinical trial in kidney transplanted patients

Dr. Lori J West, Canada
Enzymatic conversion of blood group A- to H-antigen in a mouse model to facilitate ABO-incompatible transplantation (ABOi Tx)

Adriana Montalvan, United States
Outcomes of solid organ transplantation recipients after Tixagevimab/Cilgavimab treatment

Mr. Pedro Ventura-Aguiar, Spain
Donor-derived cell-free DNA and gene expression profile in simultaneous pancreas-kidney transplantation

Dr. Dennis G Hooper, United States
A case study supporting the use of AUC0-12 for therapeutic drug monitoring of mycophenolic acid following liver transplantation